Grant D. Schauer

Grant D. Schauer

Auto-generated profile, based on publicly available information

Grant D. Schauer

Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins CO 80523

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KWKelsey S. Whinn
Kelsey S. Whinn
GKGurleen Kaur
Gurleen Kaur
JLJacob Lewis
Jacob Lewis
GSGrant D. Schauer
Grant D. Schauer
SMStefan H. Mueller
Stefan H. Mueller
Harshad GhodkeHarshad Ghodke
Harshad Ghodke
Limited experimental tools are available to study the consequences of collisions between DNA-bound molecular machines. Here, we repurpose a catalytically inactivated Cas9 (dCas9) construct as a generic, novel, targetable protein–DNA roadblock for studying mechanisms underlying enzymatic activities on DNA substrates in vitro. We illustrate the broad utility of this tool by demonstrating replication fork arrest by the specifically bound dCas9–guideRNA complex to arrest viral, bacterial and eukaryotic replication forks in vitro.

16 November 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
GSGrant D. Schauer
Grant D. Schauer
LSLisanne M. Spenkelink
Lisanne M. Spenkelink
JLJacob Lewis
Jacob Lewis
OYOlga Yurieva
Olga Yurieva
SMStefan H. Mueller
Stefan H. Mueller
MOMichael E. O’donnell
Michael E. O’donnell
Efficient and faithful replication of the genome is essential to maintain genome stability. Replication is carried out by a multiprotein complex called the replisome, which encounters numerous obstacles to its progression. Failure to bypass these obstacles results in genome instability and may facilitate errors leading to disease. Cells use accessory helicases that help the replisome bypass difficult barriers. All eukaryotes contain the accessory helicase Pif1, which tracks in a 5′–3′ direction on single-stranded DNA and plays a role in genome maintenance processes. Here, we reveal a previously unknown role for Pif1 in replication barrier bypass. We use an in vitro reconstituted Saccharomyces cerevisiae replisome to demonstrate that Pif1 enables the replisome to bypass an inactive (i.e., dead) Cas9 (dCas9) R-loop barrier. Interestingly, dCas9 R-loops targeted to either strand are bypassed with similar efficiency. Furthermore, we employed a single-molecule fluorescence visualization technique to show that Pif1 facilitates this bypass by enabling the simultaneous removal of the dCas9 protein and the R-loop. We propose that Pif1 is a general displacement helicase for replication bypass of both R-loops and protein blocks. Significance The replisome machine that duplicates the DNA genome encounters a variety of blocks to replication, such as DNA bound proteins, R-loops, and DNA lesions. Studies in bacterial systems demonstrate that replisome advance through blocks is facilitated by an accessory monomeric helicase that acts on the opposite strand from the replicative hexameric helicase. This report examines this issue in a eukaryotic system, using Pif1, a monomeric helicase that acts on the opposite strand from the replicative CMG helicase. The report shows that an inactive “dead” Cas9 (dCas9) protein R-loop block arrests the replisome, but Pif1 enables replisome bypass of the dCas9 R-loop block. Hence, use of monomeric helicases may have evolved to aid replisome bypass of protein-DNA and protein-bound R-loop blocks.

7 October 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
ASAlisa E. Shaw
Alisa E. Shaw
MMMattias N. Mihelich
Mattias N. Mihelich
JWJackson E. Whitted
Jackson E. Whitted
HRHannah J. Reitman
Hannah J. Reitman
ATAdam J. Timmerman
Adam J. Timmerman
GSGrant D. Schauer
Grant D. Schauer
Replication stress describes endogenous and exogenous challenges to DNA replication in the S-phase. Stress during this critical process causes helicase–polymerase decoupling at replication forks, triggering the S-phase checkpoint, which orchestrates global replication fork stalling and delayed entry into G2. The replication stressor most often used to induce the checkpoint response in yeast is hydroxyurea (HU), a clinically used chemotherapeutic. The primary mechanism of S-phase checkpoint activation by HU has thus far been considered to be a reduction of deoxynucleotide triphosphate synthesis by inhibition of ribonucleotide reductase (RNR), leading to helicase–polymerase decoupling and subsequent activation of the checkpoint, facilitated by the replisome-associated mediator Mrc1. In contrast, we observe that HU causes cell cycle arrest in budding yeast independent of both the Mrc1-mediated replication checkpoint response and the Psk1-Mrc1 oxidative signaling pathway. We demonstrate a direct relationship between HU incubation and reactive oxygen species (ROS) production in yeast and human cells and show that antioxidants restore growth of yeast in HU. We further observe that ROS strongly inhibits the in vitro polymerase activity of replicative polymerases (Pols), Pol α, Pol δ, and Pol ε, causing polymerase complex dissociation and subsequent loss of DNA substrate binding, likely through oxidation of their integral iron–sulfur (Fe-S) clusters. Finally, we present “RNR-deg,” a genetically engineered alternative to HU in yeast with greatly increased specificity of RNR inhibition, allowing researchers to achieve fast, nontoxic, and more readily reversible checkpoint activation compared to HU, avoiding harmful ROS generation and associated downstream cellular effects that may confound interpretation of results.

4 July 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
PMProjit Mukherjee
Projit Mukherjee
ASAbheerup Sarker
Abheerup Sarker
GSGrant D. Schauer
Grant D. Schauer
To ensure rapid and accurate DNA replication during S-phase, the cell uses DNA damage tolerance (DDT) pathways, leaving lesions to be repaired after completion of replication. One established DDT pathway is Translesion Synthesis (TLS), in which lesions are bypassed by specialized TLS Polymerases that work in conjunction with the replisome. Here we demonstrate that DNA Polymerase alpha (Pol α), the replicative primase/polymerase, can also unexpectedly replicate through bulky lesions in vitro . We use biochemical and single-molecule fluorescence assays to characterize cyclobutane pyrimidine dimer (CPD) TLS activity of Pol α. We observe that Pol ε, the leading strand replicative polymerase, and RPA, a single-stranded DNA binding protein complex, both strongly inhibit CPD TLS activity of Pol α. In contrast, Pol η, the canonical TLS Pol for pyrimidine dimers, is unaffected by Pol ε and is conversely stimulated by RPA. Finally, we demonstrate with single-molecule Fluorescence Resonance Energy Transfer (FRET) that the DNA binding cleft of Pol α must remain in the open state to accommodate a bulky CPD lesion during TLS, possibly accounting for the relatively slow kinetics of CPD bypass that we observe. The results suggest that the intrinsic bulky TLS activity of Pol α is likely suppressed at the replication fork by the replisome itself during normal replication. RESEARCH HIGHLIGHTS: Polymerase α has translesion synthesis (TLS) activity past a CPD lesion, the first demonstration of TLS activity at a bulky lesion by a replicative polymerase at physiological nucleotide levels. Intrinsic Pol α TLS activity is suppressed during normal replication by replisome components Pol ε and RPA. Pol ε suppresses TLS incorporation by Pol α by proofreading The binding cleft of Pol α stays open to accommodate a pyrimidine dimer. GRAPHICAL Pol α harbors CPD TLS activity that is suppressed by RPA and Pol ε at the replication fork during normal replication.

4 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAlisa E. Shaw
Alisa E. Shaw
JWJackson E. Whitted
Jackson E. Whitted
MMMattias N. Mihelich
Mattias N. Mihelich
HRHannah J. Reitman
Hannah J. Reitman
ATAdam J. Timmerman
Adam J. Timmerman
GSGrant D. Schauer
Grant D. Schauer
Replication stress describes various types of endogenous and exogenous challenges to DNA replication in S-phase. Stress during this critical process results in helicase-polymerase decoupling at replication forks, triggering the S-phase checkpoint, which orchestrates global replication fork stalling and delayed entry into G2. The replication stressor most often used to induce the checkpoint response is hydroxyurea (HU), a chemotherapeutic agent. The primary mechanism of S-phase checkpoint activation by HU has thus far been considered to be a reduction of dNTP synthesis by inhibition of ribonucleotide reductase (RNR), leading to helicase-polymerase decoupling and subsequent activation of the checkpoint, mediated by the replisome associated effector kinase Mrc1. In contrast, we observe that HU causes cell cycle arrest in budding yeast independent of both the Mrc1-mediated replication checkpoint response and the Psk1-Mrc1 oxidative signaling pathway. We demonstrate a direct relationship between HU incubation and reactive oxygen species (ROS) production in yeast nuclei. We further observe that ROS strongly inhibits the in vitro polymerase activity of replicative polymerases (Pols), Pol α, Pol δ, and Pol ε, causing polymerase complex dissociation and subsequent loss of DNA substrate binding, likely through oxidation of their integral iron sulfur Fe-S clusters. Finally, we present “RNR-deg,” a genetically engineered alternative to HU in yeast with greatly increased specificity of RNR inhibition, allowing researchers to achieve fast, nontoxic, and more readily reversible checkpoint activation compared to HU, avoiding harmful ROS generation and associated downstream cellular effects that may confound interpretation of results.

5 April 2022
Verified
Book Chapter
Closed access
ASAlisa E Shaw
Alisa E Shaw
SKSreeya Kairamkonda
Sreeya Kairamkonda
HGHarshad Ghodke
Harshad Ghodke
GSGrant D Schauer
Grant D Schauer